Tracking 858 eczema patients on breakthrough treatment

NCT ID NCT03428646

Ongoing Knowledge-focused Sponsor: Regeneron Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study follows 858 eczema patients who are starting treatment with Dupixent in real-world settings. Researchers will track how patients use the medication, monitor its effectiveness over time, and collect safety information. The goal is to understand how this treatment works outside of controlled clinical trials.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Regeneron Investigational Site

Birmingham, Alabama, 35205, United States
Regeneron Investigational Site

Gilbert, Arizona, 85234, United States
Regeneron Investigational Site

Fountain Valley, California, 92708, United States
Regeneron Investigational Site

Laguna Hills, California, 92653, United States
Regeneron Investigational Site

Loma Linda, California, 92354, United States
Regeneron Investigational Site

Los Angeles, California, 90025, United States
Regeneron Investigational Site

Los Angeles, California, 90067, United States
Regeneron Investigational Site

Manhattan Beach, California, 90266-2911, United States
Regeneron Investigational Site

Newport Beach, California, 92663, United States
Regeneron Investigational Site

Oceanside, California, 92056, United States
Regeneron Investigational Site

Redondo Beach, California, 90277, United States
Regeneron Investigational Site

Riverside, California, 92506-0174, United States
Regeneron Investigational Site

Roseville, California, 95661, United States
Regeneron Investigational Site

San Diego, California, 92123, United States
Regeneron Investigational Site

Santa Monica, California, 90404, United States
Regeneron Investigational Site

Thousand Oaks, California, 91320, United States
Regeneron Investigational Site

New Haven, Connecticut, 06519, United States
Regeneron Investigational Site

Coral Gables, Florida, 33146, United States
Regeneron Investigational Site

Margate, Florida, 33063, United States
Regeneron Investigational Site

West Palm Beach, Florida, 33406, United States
Regeneron Investigational Site

Atlanta, Georgia, 30342-1703, United States
Regeneron Investigational Site

Macon, Georgia, 31217, United States
Regeneron Investigational Site

Marietta, Georgia, 30060-1047, United States
Regeneron Investigational Site

Marietta, Georgia, 30152, United States
Regeneron Investigational Site

Sandy Springs, Georgia, 30328, United States
Regeneron Investigational Site

Champaign, Illinois, 61820, United States
Regeneron Investigational Site

Chicago, Illinois, 60654, United States
Regeneron Investigational Site

La Grange Park, Illinois, 60526, United States
Regeneron Investigational Site

Skokie, Illinois, 60077, United States
Regeneron Investigational Site

Springfield, Illinois, 62604, United States
Regeneron Investigational Site

Fort Wayne, Indiana, 46804, United States
Regeneron Investigational Site

Plainfield, Indiana, 46168, United States
Regeneron Investigational Site

Overland Park, Kansas, 66215, United States
Regeneron Investigational Site

Corbin, Kentucky, 40701, United States
Regeneron Investigational Site

Louisville, Kentucky, 40202, United States
Regeneron Investigational Site

Rockville, Maryland, 20850, United States
Regeneron Investigational Site

Towson, Maryland, 21204, United States
Regeneron Investigational Site

Upper Marlboro, Maryland, 20772, United States
Regeneron Investigational Site

White Marsh, Maryland, 21162, United States
Regeneron Investigational Site

Quincy, Massachusetts, 02169, United States
Regeneron Investigational Site

Ann Arbor, Michigan, 48103, United States
Regeneron Investigational Site

Bay City, Michigan, 48706, United States
Regeneron Investigational Site

Troy, Michigan, 48084, United States
Regeneron Investigational Site

Warren, Michigan, 48088, United States
Regeneron Investigational Site

Columbia, Missouri, 65212-0001, United States
Regeneron Investigational Site

Kirksville, Missouri, 63501, United States
Regeneron Investigational Site

St Louis, Missouri, 63110, United States
Regeneron Investigational Site

Lincoln, Nebraska, 68505, United States
Regeneron Investigational Site

Henderson, Nevada, 89052, United States
Regeneron Investigational Site

Las Vegas, Nevada, 89144, United States
Regeneron Investigational Site

Brick, New Jersey, 08724, United States
Regeneron Investigational Site

East Windsor, New Jersey, 08520, United States
Regeneron Investigational Site

Edison, New Jersey, 08820, United States
Regeneron Investigational Site

Piscataway, New Jersey, 08854, United States
Regeneron Investigational Site

Elmhurst, New York, 11373-4831, United States
Regeneron Investigational Site

Forest Hills, New York, 11374, United States
Regeneron Investigational Site

Garden City, New York, 11530, United States
Regeneron Investigational Site

Kew Gardens, New York, 11374, United States
Regeneron Investigational Site

Lake Success, New York, 11042, United States
Regeneron Investigational Site

Manhasset, New York, 11030, United States
Regeneron Investigational Site

Mineola, New York, 11501, United States
Regeneron Investigational Site

Mount Vernon, New York, 10552, United States
Regeneron Investigational Site

New York, New York, 10012-1354, United States
Regeneron Investigational Site

New York, New York, 10016, United States
Regeneron Investigational Site

New York, New York, 10029, United States
Regeneron Investigational Site

New York, New York, 10075, United States
Regeneron Investigational Site

The Bronx, New York, 10467-2401, United States
Regeneron Investigational Site

Troy, New York, 12180, United States
Regeneron Investigational Site

Concord, North Carolina, 28025, United States
Regeneron Investigational Site

Akron, Ohio, 44333, United States
Regeneron Investigational Site

Athens, Ohio, 45701, United States
Regeneron Investigational Site

Bexley, Ohio, 43209, United States
Regeneron Investigational Site

Marion, Ohio, 43302, United States
Regeneron Investigational Site

Mason, Ohio, 45040, United States
Regeneron Investigational Site

Tulsa, Oklahoma, 74136, United States
Regeneron Investigational Site

Portland, Oregon, 97239, United States
Regeneron Investigational Site

Blue Bell, Pennsylvania, 19422, United States
Regeneron Investigational Site

Philadelphia, Pennsylvania, 19107, United States
Regeneron Investigational Site

Philadelphia, Pennsylvania, 19140, United States
Regeneron Investigational Site

Sellersville, Pennsylvania, 18960, United States
Regeneron Investigational Site

Yardley, Pennsylvania, 19067, United States
Regeneron Investigational Site

Charleston, South Carolina, 29425, United States
Regeneron Investigational Site

North Charleston, South Carolina, 29420-4211, United States
Regeneron Investigational Site

Bellaire, Texas, 77401, United States
Regeneron Investigational Site

Dallas, Texas, 75231, United States
Regeneron Investigational Site

Grapevine, Texas, 76051, United States
Regeneron Investigational Site

San Antonio, Texas, 78205, United States
Regeneron Investigational Site

Sugar Land, Texas, 77478, United States
Regeneron Investigational Site

Sugar Land, Texas, 77479, United States
Regeneron Investigational Site

Arlington, Virginia, 22204, United States
Regeneron Investigational Site

Norfolk, Virginia, 23502, United States
Regeneron Investigational Site

Bellevue, Washington, 98004, United States
Regeneron Investigational Site

Milwaukee, Wisconsin, 53226, United States
Regeneron Investigational Site

Hamilton, Ontario, L8L 8E7, Canada
Regeneron Investigational Site

Markham, Ontario, L3P 1X2, Canada
Regeneron Investigational Site

Ottawa, Ontario, K1G 6G6, Canada
Regeneron Investigational Site

Peterborough, Ontario, K9J 5K2, Canada
Regeneron Investigational Site

Toronto, Ontario, M5G 1E2, Canada
Regeneron Investigational Site

Québec, G1V 4X7, Canada

Conditions

Explore the condition pages connected to this study.

DERMATITIS, ATOPIC